Bringing the fundamentals into focus…
Back to UroGen Pharma Ltd.
How UroGen Pharma Ltd. stacks up
URGN · against 1,216 other Healthcare companies
Growth
94/ 100
Near the top of its peers.
Ranked #68 of 1,217 · scores higher than 94% of peers
Bars: peers in each 10-point band of the growth score128 peers with a growth score of 90–100, including URGN · Click a bar to see the companies
Why growth scores 94?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its revenue growth and 3-year revenue growth, which are stronger than most Healthcare peers.
- Still loss-making, but the loss per share narrowed. Earnings per share growth: — vs peer median 9.8%
- faster revenue growth over three years: stronger than 90% of peers. 3-year revenue growth: 37.6% vs peer median 5.8%
- faster revenue growth over the last year: stronger than 95% of peers. Revenue growth: 100.3% vs peer median 6.1%
Metric by metric
Position: dot = URGN, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | URGN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | 100.3% | 6.1% | 95% | 33% | |
| Earnings per share growthHigher is better · 682 reported | Not reported | 9.7% | — | — | 33% |
| 3-year revenue growthHigher is better · 1,192 reported | 37.6% | 5.8% | 90% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around URGN| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 68 | 1.9B USD | 94 | 32 | |
| 68 | 20.8B THB (≈$581M) | 94 | 63 | |
| 68 | 393M USD | 94 | 61 | |
| 68 | 884M USD | 94 | 75 | |
| 68 | 1.7B USD | 94 | 31 | |
| 81 | 144.1B KRW (≈$104M) | 93 | 45 | |
| 81 | 22.1B CNY (≈$3.1B) | 93 | 49 | |
| 81 | 387M USD | 93 | 49 | |
| 81 | 815M USD | 93 | 53 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score